
In a noteworthy legal development, the New Jersey district court made a significant ruling in the case against Johnson & Johnson (J&J), involving allegations of breaching fiduciary duties and mismanaging its prescription-drug benefits program under the Employee Retirement Income Security Act (ERISA). The plaintiff brought serious claims against J&J, accusing the company of making a deal with a pharmacy benefit










